Cargando…

Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease

AIM: To develop a MRI-based method for accurate determination of liver volume (LV) and to explore the effect of long-term everolimus (EVR) treatment on LV in PCK rats with hepatomegaly. METHODS: Thirty-one female PCK rats (model for polycystic-liver-disease: PCLD) were randomized into 3 groups and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Temmerman, Frederik, Chen, Feng, Libbrecht, Louis, Vander Elst, Ingrid, Windmolders, Petra, Feng, Yuanbo, Ni, Yicheng, De Smedt, Humbert, Nevens, Frederik, van Pelt, Jos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558113/ https://www.ncbi.nlm.nih.gov/pubmed/28852309 http://dx.doi.org/10.3748/wjg.v23.i30.5499

Ejemplares similares

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Is autophagy the culprit of cystogenesis in polycystic kidney disease?
por: Wang, Shixuan, et al.
Publicado: (2020)

Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD
por: du Plessis, Johannie, et al.
Publicado: (2016)

A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma()
por: Dekervel, Jeroen, et al.
Publicado: (2016)

Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
por: Reiterová, Jana, et al.
Publicado: (2022)

Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice
por: Verbeek, Jef, et al.
Publicado: (2017)

Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease
por: Sweeney, William E, et al.
Publicado: (2017)

Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease
por: Cruz, Nelly M., et al.
Publicado: (2017)

Effect of Trehalose Supplementation on Autophagy and Cystogenesis in a Mouse Model of Polycystic Kidney Disease
por: Chou, Li-Fang, et al.
Publicado: (2018)

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
por: Caballero‐Camino, Francisco J., et al.
Publicado: (2020)

AI-based MRI auto-segmentation of brain tumor in rodents, a multicenter study
por: Wang, Shuncong, et al.
Publicado: (2023)

Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis
por: Patera, Foteini, et al.
Publicado: (2019)

TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease
por: Lee, Eun Ji, et al.
Publicado: (2020)

Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease
por: Masyuk, Tatyana, et al.
Publicado: (2021)

Novel zebrafish polycystic kidney disease models reveal functions of the Hippo pathway in renal cystogenesis
por: Ren, Zhiqin, et al.
Publicado: (2021)

Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease
por: Li, Sienna R., et al.
Publicado: (2022)

Cilia-Localized Counterregulatory Signals as Drivers of Renal Cystogenesis
por: Walker, Rebecca V., et al.
Publicado: (2022)

Ciliary exclusion of Polycystin-2 promotes kidney cystogenesis in an autosomal dominant polycystic kidney disease model
por: Walker, Rebecca V., et al.
Publicado: (2019)

Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers
por: Liu, Ye-Wei, et al.
Publicado: (2018)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Sexual Selection Halts the Relaxation of Protamine 2 among Rodents
por: Lüke, Lena, et al.
Publicado: (2011)

Low NO bioavailability in CCl(4 )cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls
por: Van de Casteele, Marc, et al.
Publicado: (2003)

Impaired epithelial Na(+) channels activity contributes to cystogenesis and development of autosomal recessive polycystic kidney disease in PCK rats
por: Pavlov, Tengis S., et al.
Publicado: (2014)

cAMP‐Induced Nuclear Condensation of CRTC2 Promotes Transcription Elongation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease
por: Mi, Zeyun, et al.
Publicado: (2022)

Mechanism of cystogenesis in nephrotic kidneys: a histopathological study
por: Saraga, Marijan, et al.
Publicado: (2014)

Centrosome amplification disrupts renal development and causes cystogenesis
por: Dionne, Lai Kuan, et al.
Publicado: (2018)

The role of the exocyst in renal ciliogenesis, cystogenesis, tubulogenesis, and development
por: Lipschutz, Joshua H.
Publicado: (2019)

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
por: Di Malta, Chiara, et al.
Publicado: (2023)

TRPV4 functional status in cystic cells regulates cystogenesis in autosomal recessive polycystic kidney disease during variations in dietary potassium
por: Pyrshev, Kyrylo, et al.
Publicado: (2023)

MDCK Cystogenesis Driven by Cell Stabilization within Computational Analogues
por: Engelberg, Jesse A., et al.
Publicado: (2011)

Ex Vivo Modeling of Chemical Synergy in Prenatal Kidney Cystogenesis
por: Anders, Corina, et al.
Publicado: (2013)

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure
por: Laleman, Wim, et al.
Publicado: (2006)

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
por: Verbeke, Len, et al.
Publicado: (2016)

Fibrocystin/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis
por: Walker, Rebecca V, et al.
Publicado: (2023)

Putting a Halt to HALT: Does Anticoagulation Matter?
por: DeAnda, Abe, et al.
Publicado: (2022)

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018)

Ciliary ARL13B inhibits developmental kidney cystogenesis in mouse
por: Van Sciver, Robert E., et al.
Publicado: (2023)

Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model
por: Amleh, Athar, et al.
Publicado: (2023)

Accelerated cystogenesis by dietary protein load is dependent on, but not initiated by kidney macrophages
por: Sedaka, Randee, et al.
Publicado: (2023)

Questionnaire PLD‐complaint‐specific assessment identifies need for therapy in polycystic liver disease: A multi‐centric prospective study
por: Billiet, Antoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bn34qva274775go91alsrp560